The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials (clinicaltrials.gov) - Oct 3, 2026 - P4 | N=210 | Recruiting | Sponsor: Pfizer | N=46 ➔ 210 | Trial completion date: Jul 2029 ➔ Jun 2032
Enrollment change • Trial completion date • Oncology • Solid Tumor
|